World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21483
World Ranking
17623
National Ranking
663

Frits A. Wijburg publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Frits A. Wijburg sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 384 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Frits A. Wijburg D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Frits A. Wijburg sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Frits A. Wijburg is affiliated with the University of Amsterdam in the Netherlands and has a significant research presence in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their scholarly contributions span interdisciplinary topics, particularly focusing on metabolism, genetic disorders, and neurodevelopmental conditions.

The primary areas of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broader fields, Wijburg's work further specializes in several subfields such as Clinical Biochemistry, Molecular Biology, Genetics, Physiology, and Pediatrics, Perinatology, and Child Health.

  • Clinical Biochemistry
  • Molecular Biology
  • Genetics
  • Physiology
  • Pediatrics, Perinatology and Child Health

The range of main research topics covered by Wijburg includes Metabolism and Genetic Disorders, Lysosomal Storage Disorders Research, Family and Disability Support Research, Genetics and Neurodevelopmental Disorders, Mitochondrial Function and Pathology, Cystic Fibrosis Research Advances, and Folate and B Vitamins Research.

  • Metabolism and Genetic Disorders
  • Lysosomal Storage Disorders Research
  • Family and Disability Support Research
  • Genetics and Neurodevelopmental Disorders
  • Mitochondrial Function and Pathology
  • Cystic Fibrosis Research Advances
  • Folate and B Vitamins Research

Notable recent papers authored or co-authored by Wijburg include:

  • Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency, 2020, Journal of Inherited Metabolic Disease
  • Systematic Review of N-of-1 Studies in Rare Genetic Neurodevelopmental Disorders, 2021, Neurology
  • Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor, 2020, Frontiers in Cell and Developmental Biology
  • Nutritional ketosis improves exercise metabolism in patients with very long-chain acyl-CoA dehydrogenase deficiency, 2020, Journal of Inherited Metabolic Disease
  • High dose genistein in Sanfilippo syndrome: A randomised controlled trial, 2021, Journal of Inherited Metabolic Disease

Frequent co-authors collaborating with Wijburg reflect a network of expertise in related biomedical research fields. These include:

  • Gepke Visser
  • Sacha Ferdinandusse
  • Riekelt H. Houtkooper
  • Ronald J. A. Wanders
  • Frédéric M. Vaz

Publication venues where Wijburg's work appears most often include:

  • Molecular Genetics and Metabolism
  • Journal of Inherited Metabolic Disease
  • Orphanet Journal of Rare Diseases
  • European Journal of Human Genetics
  • Neurology

Best Publications

  • Elevated globotriaosylsphingosine is a hallmark of Fabry disease

    Johannes M. Aerts;Johanna E. Groener;Sijmen Kuiper;Wilma E. Donker-Koopman

  • Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia

    Matthias R Baumgartner;Friederike Hörster;Carlo Dionisi-Vici;Goknur Haliloglu

  • Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update.

    Marc C. Patterson;Christian J. Hendriksz;Mark Walterfang;Frederic Sedel

  • Sanfilippo syndrome: a mini-review.

    M. J. Valstar;G. J. G. Ruijter;O. P. van Diggelen;B. J. Poorthuis

  • Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

    Marieke Biegstraaten;Reynir Arngrímsson;Frederic Barbey;Lut Boks

  • Statin Treatment in Children With Familial Hypercholesterolemia. The Younger, the Better

    Jessica Rodenburg;Maud N. Vissers;Albert Wiegman;A. S. Paul van Trotsenburg

  • Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response

    Nick Dekker;Laura van Dussen;Carla E. M. Hollak;Herman Overkleeft

  • Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.

    Maarten Arends;Christoph Wanner;Derralynn Hughes;Atul Mehta

  • A Systematic Review and Meta-Analysis of Statin Therapy in Children With Familial Hypercholesterolemia

    H.J. Avis;M.N. Vissers;E.A. Stein;F.A. Wijburg

  • Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor.

    A. M. Motley;E. H. Hettema;E. M. Hogenhout;P. Brites

  • Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease

    S. M. Rombach;N. Dekker;M. G. Bouwman;G. E. Linthorst

  • Recommendations on the diagnosis and management of Niemann-Pick disease type C

    James E. Wraith;Matthias R. Baumgartner;Bruno Bembi;Athanasios Covanis

  • Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment

    Annet M. Bosch;Nico G. G. M. Abeling;Lodewijk IJlst;Hennie Knoester

  • Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.

    Hans R. Waterham;Frits A. Wijburg;Raoul C.M. Hennekam;Peter Vreken

  • Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy

    Thomas Cullup;Ay Lin Kho;Carlo Dionisi-Vici;Birgit Brandmeier

  • Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure

    Minke H de Ru;Jaap J Boelens;Anibh M Das;Simon A Jones

  • The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation

    Stefan Kölker;Angeles Garcia Cazorla;Vassili Valayannopoulos;Allan M. Lund

  • Disease and patient characteristics in NP-C patients: findings from an international disease registry.

    Marc C Patterson;Eugen Mengel;Frits A Wijburg;Audrey Muller

  • Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: Clinical Presentation and Follow-Up of 50 Patients

    Margarethe E. J. den Boer;Ronald J. A. Wanders;Andrew A. M. Morris;Lodewijk IJlst

  • The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

    Stefan Kölker;Vassili Valayannopoulos;Alberto B. Burlina;Jolanta Sykut-Cegielska

Frequent Co-Authors

Ronald J.A. Wanders
Ronald J.A. Wanders University of Amsterdam
Lodewijk IJlst
Lodewijk IJlst University of Amsterdam
Hans R. Waterham
Hans R. Waterham University of Amsterdam
Simon Jones
Simon Jones Microsoft (United States)
Marinus Duran
Marinus Duran University of Amsterdam
Roberto Giugliani
Roberto Giugliani Federal University of Rio Grande do Sul
Sacha Ferdinandusse
Sacha Ferdinandusse University of Amsterdam
Johannes M. F. G. Aerts
Johannes M. F. G. Aerts Leiden University
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Jos P.N. Ruiter
Jos P.N. Ruiter University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in medicine but want flexible pathways, online health and nursing degrees offer practical alternatives. For those aiming to enter the nursing field quickly, cheapest online accelerated bsn programs provide a fast-track option for earning a Bachelor of Science in Nursing (BSN) online. These programs are particularly suitable for individuals with a prior degree seeking a career change.

Registered nurses can advance their credentials through cheapest bsn programs, which allow working professionals to obtain a BSN degree while balancing responsibilities. For those aiming for top leadership or research roles, the cheapest dnp programs offer an affordable path to a Doctor of Nursing Practice (DNP) degree, opening doors to advanced practice and teaching positions.

Additionally, individuals with a non-nursing background can pursue direct entry msn programs for non-nurses online. These programs provide a streamlined route to become a qualified nurse or nursing leader even if you hold a degree in another field. Exploring these options can broaden your healthcare career opportunities beyond traditional medical school routes.

Best Scientists Citing Frits A. Wijburg

Trending Scientists